Design, synthesis and biological evaluation of γ-lactam hydroxamate based TACE inhibitors

被引：8

作者：

Argade, Anil ^{[1
,2
]}

Bahekar, Rajesh ^{[1
]}

Desai, Jigar ^{[1
]}

Thombare, Pravin ^{[1
]}

Shah, Kiran ^{[1
]}

Gite, Sanjay ^{[1
]}

Sunder, Rajesh ^{[1
]}

Ranvir, Ramchandra ^{[1
]}

Bandyopadhyay, Debdutta ^{[1
]}

Chakrabarti, Ganes ^{[1
]}

Joharapurkar, Amit ^{[1
]}

Mahapatra, Jogeswar ^{[1
]}

Chatterjee, Abhijit ^{[1
]}

Patel, Harilal ^{[1
]}

Shaikh, Mubeen ^{[1
]}

Sairam, Kalapatapu V. V. M. ^{[1
]}

Jain, Mukul ^{[1
]}

Patel, Pankaj ^{[1
]}

机构：

[1] Zydus Res Ctr, Ahmadabad 382210, Gujarat, India

[2] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Chem, Vadodara 390002, Gujarat, India

来源：

MEDCHEMCOMM | 2011年 / 2卷 / 10期

关键词：

ALPHA CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; SELECTIVE INHIBITORS; DISCOVERY; POTENT; METALLOPROTEINASE; DISINTEGRIN; ACIDS;

D O I：

10.1039/c0md00261e

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A new series of gamma-lactam hydroxamate based TACE inhibitors was designed mainly by introducing various substitutions at the 2nd position of the quinoline nucleus to achieve high potency and good selectivity towards TACE over matrix metalloproteases (MMPs) and ADAM-10. In ex vivo TNF-alpha inhibitory activity assays, compounds 11o and 11p were identified as the most potent compounds. The in vitro TACE inhibitory activity, selectivity over MMPs and ADAM-10 and the in vivo TNF-alpha inhibitory activities of compounds 11o and 11p were assessed and lead compound 11p was identified. Preliminary toxicity and pharmacokinetic (PK) studies were conducted for compound 11p and it showed an improved PK and clean toxicological profile compared to standard compound 1. Altogether, these results demonstrated the discovery of highly potent and selective gamma-lactam hydroxamate based TACE inhibitors which show potential for the safe and effective treatment of inflammatory diseases.

引用

页码：966 / 972

页数：7

共 50 条

[1] Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors
Choi, Eunhyun
Lee, Chulho
Park, Jung Eun
Seo, Jeong Jea
Cho, Misun
Kang, Jong Soon
Kim, Hwan Mook
Park, Song-Kyu
Lee, Kiho
Han, Gyoonhee
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (04) : 1218 - 1221
[2] Design, synthesis, and biological evaluation of tetrahydroisoquinoline based hydroxamate derivatives as HDAC 6 inhibitors for cancer therapy
Khetmalis, Yogesh Mahadu
Shree, Bakhya
Kumar, Boddupalli Venkata Siva
Schweipert, Markus
Debarnot, Cecile
Ashna, Fathima
Sankaranarayanan, Murugesan
Trinath, Jamma
Sharma, Vivek
Meyer-Almes, Franz -Josef
Sekhar, Kondapalli Venkata Gowri Chandra
JOURNAL OF MOLECULAR STRUCTURE, 2023, 1278
[3] Synthesis and biological evaluation of hydroxamate-based inhibitors of glutamate carboxypeptidase II
Stoermer, D
Liu, Q
Hall, MR
Flanary, JM
Thomas, AG
Rojas, C
Slusher, BS
Tsukamoto, T
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (13) : 2097 - 2100
[4] Structure based design, synthesis and biological evaluation of (sic)-lactam based HDAC inhibitors for cancer chemotherapy
Lee, Chulho
Choi, Eunhyun
Han, Gyoonhee
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[5] Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors: Part II
Lee, Chulho
Choi, Eunhyun
Cho, Misun
Lee, Boah
Oh, Soo Jin
Park, Song-Kyu
Lee, Kiho
Kim, Hwan Mook
Han, Gyoonhee
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 4189 - 4192
[6] Chromen-based TNF-α converting enzyme (TACE) inhibitors:: Design, synthesis, and biological evaluation
Chun, Kwangwoo
Park, Song-Kyu
Kim, Hwan Mook
Choi, Yongseok
Kim, Myung-Hwa
Park, Chun-Ho
Joe, Bo-Young
Chun, Tae Gyu
Choi, Hyun-Moo
Lee, Hee-Yoon
Hong, Sung Hee
Kim, Myung Sook
Nam, Ky-Youb
Han, Gyoonhee
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (01) : 530 - 535
[7] Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors
Lombart, Henry-Georges
Feyfant, Eric
Joseph-McCarthy, Diane
Huang, Adrian
Lovering, Frank
Sun, LinHong
Zhu, Yi
Zeng, Congmei
Zhang, Yuhua
Levin, Jeremy
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (15) : 4333 - 4337
[8] Reverse hydroxamate-based selective TACE inhibitors
Kamei, N
Tanaka, T
Kawai, K
Miyawaki, K
Okuyama, A
Murakami, Y
Arakawa, Y
Haino, M
Harada, T
Shimano, M
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) : 2897 - 2900
[9] Design, synthesis, and biological evaluation of a series of β-lactam-based prodrugs
Hakimelahi, GH
Shia, KS
Xue, CH
Hakimelahi, S
Moosavi-Movahedi, AA
Saboury, AA
Khalafi-Nezhad, A
Soltani-Rad, MN
Osyetrov, V
Wang, KP
Liao, JH
Luo, FT
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (11) : 3489 - 3498
[10] Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents
Guandalini, L.
Cellai, C.
Laurenzana, A.
Scapecchi, S.
Paoletti, F.
Romanelli, M. N.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (18) : 5071 - 5074

← 1 2 3 4 5 →